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Animal experiments and the development
of surgical therapiesExperimental animals have played a crucial role
in understanding fundamental biology, disease
mechanisms and the development and safety
testing of new medicines and surgical approaches.
Some of those who object to the use of animals
argue that animals have played little role in the
development of new medical and surgical treat-
ments, or have even hampered progress. This view
is difficult to justify in light of the vast weight of
evidence to the contrary. Even a brief summary of
the development of surgical therapies reveals the
contribution of animal research.
The division between medical and surgical re-
search is often blurred; for example, the discovery
of insulin, a medical treatment, was done surgi-
cally, by Banting and Best, using dogs, but the
discovery of the H2 receptor antagonists, by Sir
James Black, removed the treatment of gastroin-
testinal ulcers from the domain of the surgeon to
that of the physician.
Early history
Galen’s concept of the shuttlewise ebb and flow of
blood held sway for 14 centuries, until William
Harvey (1578e1657) discovered that blood circu-
lates. He demonstrated this on small animals such
as snakes and rabbits.1 A century later, Stephen
Hales, vicar of Teddington, England, fastened
a glass tube inside a horse’s artery, thereby
discovering and measuring blood pressure, the
capacity of the heart, and the flow rate in vessels.
Until the middle of the 19th century, operative
surgery consisted mainly of cataract removal,
cutting for bladder stones and amputations for
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Pepys was ‘‘cut for stone’’ in March 1658, and
a few months later attended the funeral of a friend
who died after being operated on by the same
surgeon.2 The novelist Fanny Burney described the
mastectomy she underwent in 1812. The operation
lasted seventeen and a half minutes and she could
not forbear from screaming with pain throughout.
Afterwards, she wrote, ‘‘I saw my good Dr Larry,
pale nearly as myself, his face streaked with
blood, & its expression depicting grief, apprehen-
sion, and almost horrour [sic].’’3 This anecdote
serves as an appropriate reminder that the history
of animal experiments in the development of
anaesthesia is of equal importance as that for
the development of surgical technique.
The development of effective sutures, safe
anaesthesia, post-operative infection control,
open heart surgery, immunosuppression, and mod-
ern techniques such as keyhole surgery or operat-
ing on the foetus, all depended on 20th century
biomedical science and careful animal experimen-
tation.
Anaesthesia
The early history of anaesthesia is poorly docu-
mented and hence the subject of controversy.4 In
1848, Thomas Wakley, founder of The Lancet,
tested chloroform and ether on a variety of
animals. Both were toxic, but more animals died
under chloroform than under ether.5
Improvements followed in equipment to deliver
inhaled anaesthetics, and animal research led to
the development of safer mixtures of gases and
methods to measure their flow. Nitrous oxide, theblished by Elsevier Ltd. All rights reserved.
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ties, was favoured from the 1860s when it became
available in compressed form in cylinders.6 Hum-
phrey Davy had experimented with the effects of
nitrous oxide on cats, and on himself, in the 18th
century. In 1920, delivery improved with the
invention of the endotracheal tube; the develop-
ment of further gaseous and volatile liquid anaes-
thetics followed. Cyclopropane in air was shown to
be useful in animals and humans but, like the
earlier anaesthetics, it was flammable.7,8
The development from the 1950s of modern,
non-flammable, safer inhaled anaesthetics de-
pended equally on animal research. Experiments
on rodents, rabbits, dogs, cats and monkeys
showed that the volatile halothane, mixed with
oxygen or air, was easy to use, produced rapid
anaesthesia and recovery, had minimal side ef-
fects, and had the added advantage of some
muscle relaxation. Effective doses of the most
widely used modern intravenous barbiturate an-
aesthetic, thiopentone sodium, were established
by research in rats, rabbits and dogs.9
Local anaesthetics
Around the same time that nitrous oxide replaced
chloroform, rabbit research paved the way for use
of cocaine as a local anaesthetic in eye surgery.
Intraspinal injection of cocaine in the dog caused
numbness of the hind legs, paving the way for use
of local anaesthetics for spinal anaesthesia. How-
ever, the toxicity of cocaine soon became clear,
and around 190010 the less toxic procaine was
synthesised and widely used until the development
of lignocaine in 1948. In tests on rabbit corneas,
lignocaine was shown to be more effective and
faster-acting.11 Its low toxicity was established in
rodents.
Sutures
Alexis Carrel was the first American to be awarded
a Nobel Prize. In his Nobel Prize lecture of 1912, he
described how he had developed an effective
technique for suturing blood vessels: ‘‘I began to
investigate by what means a vascular anastomosis
might be effected without producing either steno-
sis or thrombosis. Many surgeons had previously to
myself performed vascular anastomosis, but the
results were far from satisfactory..’’ He went on
to describe his experiments on living cats and dogs
and concluded, ‘‘As a result the study of vascularanastomosis can today be considered as completed
from the standpoints both of the technique and of
the experimental results.’’12 He used extremely
fine needles and the thinnest linen thread used by
the lacemakers of Valenciennes. He found by
experiment that it was important to protect the
endothelial layer, obvious today following the
discovery of many important factors known to be
released by these cells.
Anticoagulants
When John Abel experimented with kidney dialysis
in dogs and rabbits around 1915, he prevented
coagulation using hirudin13 extracted from leeches.
It was expensive, difficult to extract e early
preparations were very impure e caused severe
cardiovascularerespiratory side effects and allergic
reactions, and was thus unsuitable for human use.
Heparin was first isolated from dog liver and
shown to work well during animal studies. It could
be extracted in large quantities from beef liver and
lung, allowing perfection of purification techni-
ques. In 1937 purified extracts were obtained which
were shown to be effective and caused no ill effects
in dogs, rabbits, guinea pigs and mice, and sub-
sequently in human patients.14 Heparin is still
prepared from animal sources and each batch is
assessed in anaesthetised animals to ensure the
absence of substances that may cause hypotension.
Transplantation and
immunosuppression
The first human corneal transplant was in 1907 by
Zwirn.1 This followed almost a century of experi-
ments using animals, mainly rabbits. Rejection is
rarely a problem because the cornea is not
normally vascularised.
Around that time, using his new suturing tech-
nique, Carrel found that dog and cat renal auto-
grafts were successful.16 But a kidney transplanted
from a different animal of the same species ceased
to work after a few days. He therefore concluded
that although the surgery worked well, other
‘‘biological factors’’ in the host caused changes
to the kidney grafted from another animal.
The first kidney transplants leading to long-term
survival were dog autografts performed in the
1950s in Boston by Dr Joseph Murray.17 He also
carried out the first human kidney transplant,
between identical twins, in 1954.18
A development of great significance came in
1959 when Robert Schwartz and William Dameshek
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6-mercaptopurine (6-MP), was an immunosuppres-
sant.19 Roy Calne, then a young surgeon in London,
promptly used it in renal transplants between dogs
and found they survived for six weeks, six times
longer than before. On Sir Peter Medawar’s sug-
gestion, he went to Harvard to work with Joe
Murray’s team. Together, they perfected kidney
transplants in dogs, using 6-MP and a new less toxic
analogue, azathioprine.17 They then went on to
perform the first successful human unrelated-
donor transplant in 1962.
The genetic basis of tissue typing, which ensures
the best long-term survival of grafts, was worked
out using animals in 1965. Five Nobel prizes (Alexis
Carrel in 1912, Peter Medawar in 1960, George
Snell in 1980, George Hitchings in 1988, Joe Murray
in 1990) were awarded for different aspects of
research, mainly on animals, that has assisted the
success of transplantation.18
Cardiac bypass
Cardiac bypass using an external circulation was
first tried with partial success by John Gibbon in
the late 1930s using cats. During these early
experiments, Gibbon tested various types of pump
and oxygenator. He developed an artificial lung
based on a spinning hollow cylinder into which the
blood was trickled. After World War II, Gibbon and
his colleagues started extensive experiments in
dogs to test the effects of the prolonged passage
of blood through an artificial lung and total
exclusion of the heart and lungs from the circula-
tion. Having overcome the problem of multiple
small blood clots by installing a fine filter in the
circuit, and practicing actual cardiac bypass on the
dogs, by the early 1950s the mortality in dogs was
down to 12%.22
Gibbon performed the first open heart opera-
tions using heart lung machines on human patients
soon after. The first successful operation was on an
18-year-old girl who had developed right heart
failure due to an atrial septal defect.23 A 45-min
operation was performed to correct the defect,
the patient made a complete recovery and was
recorded as being alive and well 5 years later.
Cold cardioplegia
During these early operations, the heart continued
to beat, causing leakage of blood and severe
difficulty for the surgeon, presented with a moving
target. Experiments using dogs, rabbits and ratsestablished that potassium citrate could be used to
safely arrest the heart and that cold cardioplegia
would protect it in this state.24e26
Replacement heart valves
Serious and established valvular disease was un-
treatable until the 1950s. From this time there
were many attempts to mimic the anatomy of
mitral valves using artificial materials. At the same
time teams were modifying valves obtained from
pigs to prevent rejection. Following work in rab-
bits, guinea pigs and rats,27 a biologically inert,
functional and durable valve was produced by
washing, denaturing and tanning processes. Such
valves, usually from pigs, have been used clinically
since the 1970s.
Around 1960, Albert Starr developed a simple
caged ball valve which, used in dogs, brought
survival times of 13 months. These long survival
times allowed assessment of the valves’ effective-
ness and the subsequent need for anticoagu-
lants.28 The results encouraged Starr to try
replacing mitral valves in patients. By October
1961, of the 12 patients who had received artificial
mitral valves, two had died from unrelated causes,
and three from infections. The remaining patients
were well and two had returned to work.
The BjorkeShiley tilting disk valve was intro-
duced in 1969, and bi-leaflet, pivot designs were
introduced in the 1970s.29
Minimally invasive surgery
Keyhole surgery was developed in laboratory ani-
mals before being tried in humans. For example,
young pigs were used to test suturing of bilioenteric
anastomoses, which conveyed bile satisfactorily
after ligation of the common bile duct.30
The ‘Parkinson’s pacemaker’
By the end of 2004, 30,000 patients around the
world with severe, treatment-resistant Parkinson’s
disease had their lives transformed by an elec-
tronic implant that prevents the severe dyskynesia
that blight the lives of severely affected patients.
The technique is known as deep brain stimulation,
or DBS, and involves stimulation of the subthalamic
nucleus via a thin-as-a-hair implanted wire pow-
ered by a battery-driven microcomputer under the
collarbone. DBS has been developed by research
20 Editorialon rhesus macaques and it is impossible to see how
these advances could have come about without
primate research.31
Validity of animal research
The importance of animal research in the historical
development of new medicines and surgical ap-
proaches cannot be taken as evidence that all
animal research is valid and readily applicable to
human disease, or that alternative approaches
should not be sought, or that the use of animals
will always be essential.
Animals are likely to continue to be essential in
the search to understand and treat the many
diseases affecting humans and animals, including
newly emerging conditions, but there is no room
for complacency. Animal models do not always
mimic human disease and there are important and
known species differences in response to inter-
ventions. For these reasons, there are continued
efforts to assess the value of animal research and
to develop alternatives.
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